{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T14:55:26Z","timestamp":1782226526749,"version":"3.54.5"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T00:00:00Z","timestamp":1574812800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T00:00:00Z","timestamp":1574812800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["XXX"],"award-info":[{"award-number":["XXX"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001729","name":"Stiftelsen f\u00f6r\u00a0Strategisk Forskning","doi-asserted-by":"publisher","award":["xx"],"award-info":[{"award-number":["xx"]}],"id":[{"id":"10.13039\/501100001729","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006310","name":"Medicinska Forskningsr\u00e5det","doi-asserted-by":"publisher","award":["XX"],"award-info":[{"award-number":["XX"]}],"id":[{"id":"10.13039\/501100006310","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Objective<\/jats:title>\n<jats:p>This study was performed to evaluate the use of high-risk HPV (hrHPV) viral load in screening tests for cervical cancer to predict persistent infection and presence of cervical intraepithelial neoplasia grade 2 or worse (CIN2+).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>We followed women between 30 and 60\u2009years of age who performed self-sampling of vaginal fluid and subsequently a hrHPV test. Women who were hrHPV positive in their screening test repeated the hrHPV test 3\u20136\u2009months later and were included in the present study.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Our results show that women with a persistent HPV16 infection had higher HPV viral load in their primary screening test than women with transient infections (<jats:italic>p<\/jats:italic>\u00a0=\u20095.33e-03). This was also true for sum of viral load for all hrHPV types in the primary screening test (<jats:italic>p<\/jats:italic>\u00a0=\u20093.88e-07). 48% of women with persistent HPV16 infection and CIN2+ had an increase in HPV16 titer in the follow-up test, as compared to only 20% of women with persistent infection but without CIN2+ lesions. For the sum of all hrHPV types, 41% of women with persistent infection and CIN2+ had an increase in titer as compared to 26% of women without CIN2\u2009+\u2009.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>The results show that hrHPV viral load in the primary screening HPV test is associated with the presence of CIN2+ and could be used in triaging hrHPV positive women for different follow-up strategies or recall times. Serial testing of hrHPV viral load has the potential to distinguish women with CIN2+ lesions from women with persistent infection but without CIN2+ lesions.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12985-019-1253-2","type":"journal-article","created":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T03:02:47Z","timestamp":1574823767000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["HPV viral load in self-collected vaginal fluid samples as predictor for presence of cervical intraepithelial neoplasia"],"prefix":"10.1186","volume":"16","author":[{"given":"Malin","family":"Berggrund","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inger","family":"Gustavsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riina","family":"Aarnio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Hedlund-Lindberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Sanner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Wikstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Enroth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matts","family":"Olovsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6316-3355","authenticated-orcid":false,"given":"Ulf","family":"Gyllensten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,27]]},"reference":[{"key":"1253_CR1","volume-title":"Pavon MA","author":"S de Sanjose","year":"2017","unstructured":"de Sanjose S, Brotons M. Pavon MA. Best Pract Res Clin Obstet Gynaecol: The natural history of human papillomavirus infection; 2017."},{"key":"1253_CR2","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jcv.2011.05.006","volume":"51","author":"I Gustavsson","year":"2011","unstructured":"Gustavsson I, Sanner K, Lindell M, Strand A, Olovsson M, Wikstrom I, et al. Type-specific detection of high-risk human papillomavirus (HPV) in self-sampled cervicovaginal cells applied to FTA elute cartridge. J Clin Virol. 2011;51:255\u20138.","journal-title":"J Clin Virol"},{"key":"1253_CR3","doi-asserted-by":"crossref","unstructured":"Gustavsson I, Aarnio R, Berggrund M, Hedlund-Lindberg J, Strand AS, Sanner K, et al. Randomised study shows that repeated self-sampling and HPV test has more than two-fold higher detection rate of women with CIN2+ histology than pap smear cytology. Br J Cancer. 2018.","DOI":"10.1038\/bjc.2017.485"},{"key":"1253_CR4","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1097\/LGT.0b013e31824ca9d5","volume":"16","author":"D Saslow","year":"2012","unstructured":"Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain JM, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. J Low Genit Tract Dis. 2012;16:175\u2013204.","journal-title":"J Low Genit Tract Dis."},{"key":"1253_CR5","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/modpathol.2016.168","volume":"30","author":"E Miralpeix","year":"2017","unstructured":"Miralpeix E, Genoves J, Maria Sole-Sedeno J, Mancebo G, Lloveras B, Bellosillo B, et al. Usefulness of p16(INK4a) staining for managing histological high-grade squamous intraepithelial cervical lesions. Mod Pathol. 2017;30:304\u201310.","journal-title":"Mod Pathol"},{"key":"1253_CR6","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1128\/JCM.37.4.1030-1034.1999","volume":"37","author":"DC Swan","year":"1999","unstructured":"Swan DC, Tucker RA, Tortolero-Luna G, Mitchell MF, Wideroff L, Unger ER, et al. Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type. J Clin Microbiol. 1999;37:1030\u20134.","journal-title":"J Clin Microbiol"},{"key":"1253_CR7","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/S0090-8258(03)00320-2","volume":"90","author":"DM Hernandez-Hernandez","year":"2003","unstructured":"Hernandez-Hernandez DM, Ornelas-Bernal L, Guido-Jimenez M, Apresa-Garcia T, Alvarado-Cabrero I, Salcedo-Vargas M, et al. Association between high-risk human papillomavirus DNA load and precursor lesions of cervical cancer in Mexican women. Gynecol Oncol. 2003;90:310\u20137.","journal-title":"Gynecol Oncol"},{"key":"1253_CR8","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/jmv.24645","volume":"89","author":"Z Wu","year":"2017","unstructured":"Wu Z, Qin Y, Yu L, Lin C, Wang H, Cui J, et al. Association between human papillomavirus (HPV) 16, HPV18, and other HR-HPV viral load and the histological classification of cervical lesions: results from a large-scale cross-sectional study. J Med Virol. 2017;89:535\u201341.","journal-title":"J Med Virol"},{"key":"1253_CR9","unstructured":"Manawapat-Klopfer A, Wang L, Haedicke-Jarboui J, Stubenrauch F, Munk C, Thomsen LT, et alHPV16 viral load and physical state measurement as a potential immediate triage strategy for HR-HPV-infected women: a study in 644 women with single HPV16 infections Am J Cancer Res 2018;8:715\u201322."},{"key":"1253_CR10","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jcv.2016.07.020","volume":"83","author":"P van der Weele","year":"2016","unstructured":"van der Weele P, van Logchem E, Wolffs P, van den Broek I, Feltkamp M, de Melker H, et al. Correlation between viral load, multiplicity of infection, and persistence of HPV16 and HPV18 infection in a Dutch cohort of young women. J Clin Virol. 2016;83:6\u201311.","journal-title":"J Clin Virol"},{"key":"1253_CR11","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1002\/cam4.473","volume":"4","author":"CE Depuydt","year":"2015","unstructured":"Depuydt CE, Jonckheere J, Berth M, Salembier GM, Vereecken AJ, Bogers JJ. Serial type-specific human papillomavirus (HPV) load measurement allows differentiation between regressing cervical lesions and serial virion productive transient infections. Cancer Med. 2015;4:1294\u2013302.","journal-title":"Cancer Med"},{"key":"1253_CR12","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1002\/ijc.30238","volume":"139","author":"CE Depuydt","year":"2016","unstructured":"Depuydt CE, Thys S, Beert J, Jonckheere J, Salembier G, Bogers JJ. Linear viral load increase of a single HPV-type in women with multiple HPV infections predicts progression to cervical cancer. Int J Cancer. 2016;139:2021\u201332.","journal-title":"Int J Cancer"},{"key":"1253_CR13","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1097\/CEJ.0000000000000241","volume":"26","author":"S Verhelst","year":"2017","unstructured":"Verhelst S, Poppe WA, Bogers JJ, Depuydt CE. Serial measurement of type-specific human papillomavirus load enables classification of cervical intraepithelial neoplasia lesions according to occurring human papillomavirus-induced pathway. Eur J Cancer Prev. 2017;26:156\u201364.","journal-title":"Eur J Cancer Prev"},{"key":"1253_CR14","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1016\/S0140-6736(00)02401-6","volume":"355","author":"AM Josefsson","year":"2000","unstructured":"Josefsson AM, Magnusson PK, Ylitalo N, Sorensen P, Qwarforth-Tubbin P, Andersen PK, et al. Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet. 2000;355:2189\u201393.","journal-title":"Lancet"},{"key":"1253_CR15","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1016\/S0140-6736(00)02402-8","volume":"355","author":"N Ylitalo","year":"2000","unstructured":"Ylitalo N, Sorensen P, Josefsson AM, Magnusson PK, Andersen PK, Ponten J, et al. Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study. Lancet. 2000;355:2194\u20138.","journal-title":"Lancet."},{"issue":"5","key":"1253_CR16","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/sj.bjc.6602436","volume":"92","author":"M Moberg","year":"2005","unstructured":"Moberg M, Gustavsson I, Wilander E, Gyllensten UHigh viral loads of human papillomavirus predict risk of invasive cervical carcinoma. Br J Cancer 2005;92:891\u20134.","journal-title":"British Journal of Cancer"},{"key":"1253_CR17","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1093\/infdis\/jir049","volume":"203","author":"LF Xi","year":"2011","unstructured":"Xi LF, Hughes JP, Castle PE, Edelstein ZR, Wang C, Galloway DA, et al. Viral load in the natural history of human papillomavirus type 16 infection: a nested case-control study. J Infect Dis. 2011;203:1425\u201333.","journal-title":"J Infect Dis"},{"key":"1253_CR18","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/jmv.23190","volume":"84","author":"X Carcopino","year":"2012","unstructured":"Carcopino X, Henry M, Mancini J, Giusiano S, Boubli L, Olive D, et al. Significance of HPV 16 and 18 viral load quantitation in women referred for colposcopy. J Med Virol. 2012;84:306\u201313.","journal-title":"J Med Virol"},{"key":"1253_CR19","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1158\/1055-9965.EPI-12-1067","volume":"22","author":"M Schmitt","year":"2013","unstructured":"Schmitt M, Depuydt C, Benoy I, Bogers J, Antoine J, Pawlita M, et al. Viral load of high-risk human papillomaviruses as reliable clinical predictor for the presence of cervical lesions. Cancer Epidemiol Biomark Prev. 2013;22:406\u201314.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"1253_CR20","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/LGT.0000000000000277","volume":"21","author":"H Luo","year":"2017","unstructured":"Luo H, Belinson JL, Du H, Liu Z, Zhang L, Wang C, et al. Evaluation of viral load as a triage strategy with primary high-risk human papillomavirus cervical Cancer screening. J Low Genit Tract Dis. 2017;21:12\u20136.","journal-title":"J Low Genit Tract Dis"},{"key":"1253_CR21","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ygyno.2017.11.016","volume":"148","author":"L Dong","year":"2018","unstructured":"Dong L, Wang MZ, Zhao XL, Feng RM, Hu SY, Zhang Q, et al. Human papillomavirus viral load as a useful triage tool for non-16\/18 high-risk human papillomavirus positive women: a prospective screening cohort study. Gynecol Oncol. 2018;148:103\u201310.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"1253_CR22","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1158\/1055-9965","volume":"19","author":"C Constandinou-Williams","year":"2010","unstructured":"Constandinou-Williams C, Collins SI, Roberts S, Young LS, Woodman CBJ, Murray PG, Is human papillomavirus viral load a clinically useful predictive marker. A longitudinal study. Cancer Epidemiol biomarkers Prev. March. 2010;19(3):832\u20137. https:\/\/doi.org\/10.1158\/1055-9965.","journal-title":"March"},{"key":"1253_CR23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/ijc.31637","volume":"144","author":"I Gustavsson","year":"2019","unstructured":"Gustavsson I, Aarnio R, Berggrund M, Hedlund-Lindberg J, Sanner K, Wikstrom I, et al. Randomised study of HPV prevalence and detection of CIN2+ in vaginal self-sampling compared to cervical specimens collected by medical personnel. Int J Cancer. 2019;144:89\u201397.","journal-title":"Int J Cancer"},{"key":"1253_CR24","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jcv.2009.06.021","volume":"46","author":"I Gustavsson","year":"2009","unstructured":"Gustavsson I, Lindell M, Wilander E, Strand A, Gyllensten U. Use of FTA card for dry collection, transportation and storage of cervical cell specimen to detect high-risk HPV. J Clin Virol. 2009;46:112\u20136.","journal-title":"J Clin Virol"},{"issue":"7","key":"1253_CR25","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1128\/JCM.41.7.3221-3228.2003","volume":"41","author":"M. Moberg","year":"2003","unstructured":"Moberg M, Gustavsson I, Gyllensten U. Real-time PCR-based system for simultaneous quantification of human papillomavirus types associated with high risk of cervical cancer. J Clin Microbiol, 2003. 41:3221\u20138.","journal-title":"Journal of Clinical Microbiology"},{"issue":"16","key":"1253_CR26","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12985-019-1216-7","volume":"(1)","author":"I Gustavsson","year":"2019","unstructured":"Gustavsson I, Aarnio R, Myrnas M, Hedlund-Lindberg J, Taku O, Meiring T, et al. Clinical validation of the HPVIR high-risk HPV test on cervical samples according to the international guidelines for human papillomavirus DNA test requirements for cervical cancer screening. Virol J. 2019;(1)(16):107.","journal-title":"Virol J"},{"key":"1253_CR27","unstructured":"Core R. Team. R: a language and environment for statistical computing.: R Foundation for Statistical. Computing. 2014."},{"key":"1253_CR28","unstructured":"Aragon TJ. epitools: Epidemiology Tools. 2017."},{"key":"1253_CR29","first-page":"1","volume":"28","author":"M Kuhn","year":"2008","unstructured":"Kuhn M. Building predictive models in R using the caret package. J Statistical Software, Articles. 2008;28:1\u201326.","journal-title":"J Statistical Software, Articles"},{"key":"1253_CR30","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"R Xavier","year":"2011","unstructured":"Xavier R, Natacha T, Alexandre H, Natalia T, Fr\u00e9d\u00e9rique L, Jean-Charles S, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics. 2011;12:77.","journal-title":"BMC Bioinformatics"},{"key":"1253_CR31","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1186\/s12885-016-2518-4","volume":"16","author":"S Preisler","year":"2016","unstructured":"Preisler S, Rebolj M, Ejegod DM, Lynge E, Rygaard C, Bonde J. Cross-reactivity profiles of hybrid capture II, cobas, and APTIMA human papillomavirus assays: split-sample study. BMC Cancer. 2016;16:510.","journal-title":"BMC Cancer"},{"key":"1253_CR32","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.cmi.2017.05.020","volume":"24","author":"L de Thurah","year":"2018","unstructured":"de Thurah L, Bonde J, Lam JUH, Rebolj M. Concordant testing results between various human papillomavirus assays in primary cervical cancer screening: systematic review. Clin Microbiol Infect. 2018;24:29\u201336.","journal-title":"Clin Microbiol Infect"},{"key":"1253_CR33","doi-asserted-by":"crossref","unstructured":"Dong B, Sun P, Ruan G, Huang W, Mao X, Kang Y, et al. Type-specific high-risk human papillomavirus viral load as a viable triage indicator for high-grade squamous intraepithelial lesion: a nested case- control study. Cancer Manag Res 2018;10:4839\u201351.","DOI":"10.2147\/CMAR.S179724"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-019-1253-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12985-019-1253-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-019-1253-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T00:14:43Z","timestamp":1606349683000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-019-1253-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,27]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1253"],"URL":"https:\/\/doi.org\/10.1186\/s12985-019-1253-2","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,27]]},"assertion":[{"value":"4 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Regional Ethics Committee in Uppsala (Dir. 2012\/099).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"146"}}